Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3586 AL 3600

Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS

Poewe W, Hauser RA, Lang A; ADAGIO Investigators.

Mov Disord. 2015 Apr;30(4):589-92. doi: 10.1002/mds.26124. Epub 2014 Dec 27.

Is the Parkinson Anxiety Scale comparable across raters?

Forjaz MJ, Ayala A, Martinez-Martin P, Dujardin K, Pontone GM, Starkstein SE, Weintraub D, Leentjens AF.

Mov Disord. 2015 Apr;30(4):545-51. doi: 10.1002/mds.26111. Epub 2014 Dec 27.

Stem cell reprogramming: basic implications and future perspective for movement disorders

Brändl B, Schneider SA, Loring JF, Hardy J, Gribbon P, Müller FJ.

Mov Disord. 2015 Mar;30(3):301-12. doi: 10.1002/mds.26113. Epub 2014 Dec 27.

Modifying welding process parameters can reduce the neurotoxic potential of manganese-containing welding fumes

Sriram K, Lin GX, Jefferson AM, Stone S, Afshari A, Keane MJ, McKinney W, Jackson M, Chen BT, Schwegler-Berry D, Cumpston A, Cumpston JL, Roberts JR, Frazer DG, Antonini JM.

Toxicology. 2015 Feb 3;328:168-78. doi: 10.1016/j.tox.2014.12.015. Epub 2014 Dec 27.

Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria

Jain S, Himali J, Beiser A, Ton TG, Kelly-Hayes M, Biggs ML, Delaney JA, Rosano C, Seshadri S, Frank SA.

Am J Epidemiol. 2015 Feb 1;181(3):185-90. doi: 10.1093/aje/kwu326. Epub 2014 Dec 29.

Exercise for falls prevention in Parkinson disease: a randomized controlled trial

Canning CG, Sherrington C, Lord SR, Close JC, Heritier S, Heller GZ, Howard K, Allen NE, Latt MD, Murray SM, O'Rourke SD, Paul SS, Song J, Fung VS.

Neurology. 2015 Jan 20;84(3):304-12. doi: 10.1212/WNL.0000000000001155. Epub 2014 Dec 31.

Epigenetic mechanisms in Parkinson's disease

Feng Y, Jankovic J, Wu YC.

J Neurol Sci. 2015 Feb 15;349(1-2):3-9. doi: 10.1016/j.jns.2014.12.017. Epub 2014 Dec 18.

Link between the SNCA gene and parkinsonism

Xu W, Tan L, Yu JT.

Neurobiol Aging. 2015 Mar;36(3):1505-18. doi: 10.1016/j.neurobiolaging.2014.10.042. Epub 2014 Dec 3.

Small heat shock proteins: Role in cellular functions and pathology

Bakthisaran R, Tangirala R, Rao ChM.

Biochim Biophys Acta. 2015 Apr;1854(4):291-319. doi: 10.1016/j.bbapap.2014.12.019. Epub 2014 Dec 30.

Retour aux sources: defining the structural basis of glutamate receptor activation

Dawe GB, Aurousseau MR, Daniels BA, Bowie D.

J Physiol. 2015 Jan 1;593(1):97-110. doi: 10.1113/jphysiol.2014.277921. Epub 2014 Oct 21.

Is Irish set dancing feasible for people with Parkinson's disease in Ireland?

Shanahan J, Morris ME, Bhriain ON, Volpe D, Richardson M, Clifford AM.

Complement Ther Clin Pract. 2015 Feb;21(1):47-51. doi: 10.1016/j.ctcp.2014.12.002. Epub 2014 Dec 13.

A systematic review of treatments for Impulse Control Disorders and related behaviours in Parkinson's disease

Tanwani P, Fernie BA, Nikčević AV, Spada MM.

Psychiatry Res. 2015 Feb 28;225(3):402-6. doi: 10.1016/j.psychres.2014.12.005. Epub 2014 Dec 15.

An overview on the correlation of neurological disorders with cardiovascular disease

Firoz CK, Jabir NR, Khan MS, Mahmoud M, Shakil S, Damanhouri GA, Zaidi SK, Tabrez S, Kamal MA.

Saudi J Biol Sci. 2015 Jan;22(1):19-23. doi: 10.1016/j.sjbs.2014.09.003. Epub 2014 Sep 6.

Effects of Stochastic Vestibular Galvanic Stimulation and LDOPA on Balance and Motor Symptoms in Patients With Parkinson's Disease

Samoudi G, Jivegård M, Mulavara AP, Bergquist F.

Brain Stimul. 2015 May-Jun;8(3):474-80. doi: 10.1016/j.brs.2014.11.019. Epub 2014 Dec 3.

In search of innovative therapeutics for neuropsychiatric disorders: the case of neurodegenerative diseases

Féger J, Hirsch EC.

Ann Pharm Fr. 2015 Jan;73(1):3-12. doi: 10.1016/j.pharma.2014.10.001. Epub 2014 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias